CDC-RFA-CD21-2105: Strategic Planning: Southeast Asia
Closed
This grant is closed. A newer notice from the same program is forecast: Capacity Building for National Immunization Programs in the Eastern Mediterranean Region (CDC-RFA-JG-27-0070). Status: Expected deadline February 12, 2027. It is in our archive of Centers for Disease Control - OD notices from 2021.
Centers for Disease Control - OD offered grants to any type of organization. It expected to make one award worth $250,000 in total. Applications closed on July 19, 2021.
From the official notice on Grants.gov, last changed July 6, 2021. Checked November 7, 2026.
- Total funding$250,000
- Expected awards1
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | June 17, 2021 |
|---|---|
| Deadline | July 19, 2021 |
| Archived by Grants.gov | August 18, 2021 |
Who can apply
This opportunity was open to any type of organization.
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Is this a realistic fit?
- Most of the program's money (49% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
To date, CDC has launched four regional platforms: South America, based in Brasilia, Brazil; Eastern Europe/Central Asia, based in Tbilisi, Georgia; Middle East/North Africa, based in Muscat, Oman, and Southeast Asia, based in Hanoi, Vietnam. This NOFO is specific to the Southeast Asia Region and includes the following countries: Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar (Burma), Philippines, Papua New Guinea, Thailand, Singapore, and Vietnam. The goal of this NOFO is to support the mission and goals of CDC’s global health regionalization strategy. Activities will include the planning, coordinating, and convening of annual strategic and other planning meetings to address public health priorities and capacity building for the region. Public health stakeholders in the region will communicate, coordinate, and collaborate to address regional health priorities.
Who has won Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security grants before
From fiscal 2021 to 2025, Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security (93.318) awarded $1.3 billion across 306 grant awards, an average of $4.3 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| African Field Epidemiology Network LTD | 6 | $147 million | |
| The Task Force for Global Health, Inc. | Georgia | 7 | $138 million |
| World Health Organization, Somalia | 14 | $125 million | |
| Association of Public Health Laboratories, Inc. (the) | Maryland | 3 | $61.5 million |
| The Johns Hopkins University | Maryland | 5 | $42.7 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, CDC-RFA-JG-27-0070, which is forecast.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is CDC-RFA-CD21-2105 still open?
No. It closed on July 19, 2021. A newer notice is forecast: CDC-RFA-JG-27-0070, expected deadline February 12, 2027.
Who can apply for Strategic Planning: Southeast Asia?
Centers for Disease Control - OD accepted applications from any type of organization.
What is the deadline for Strategic Planning: Southeast Asia?
Closed July 19, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
About $250,000 in total for one award.
Who has won Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security grants before?
The largest recipients over five fiscal years were African Field Epidemiology Network LTD, The Task Force for Global Health, Inc., World Health Organization, Somalia. The program made 306 awards worth $1.3 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)